ArticleThe Pan African medical journal2026
[Clear cell carcinoma of the cervix in Mauritania: a case report].
Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clear cell carcinoma (CCC) of the cervix is a rare cancer, particularly in the absence of exposure to diethylstilbestrol (DES). This case is unique because it involves a 40-year-old patient with no history of DES exposure, illustrating the diagnostic and therapeutic challenges in a resource-limited setting such as Mauritania. The patient presented with persistent vaginal bleeding, and a mass was detected during a gynaecological examination. The final diagnosis of CCC was confirmed by histopathological and immunohistochemical examination. Treatment consisted of external radiotherapy and chemotherapy, followed by an extended colpohysterectomy, without the use of brachytherapy because of technical constraints. The patient responded well to treatment, with no clinical or radiological evidence of recurrence. This case underscores the feasibility of effective multidisciplinary management of rare cervical tumors in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.